When your child receives a diagnosis that doctors describe as “ultra-rare,” the world shifts under your feet. Suddenly, you’re not just a parent — you’re a researcher, an advocate, a full-time coordinator of a medical puzzle with missing pieces. For many families facing these conditions, the daily reality involves juggling appointments, deciphering insurance paperwork, and desperately searching for answers that seem scattered across forums and scattered conversations.
One mother, a tech entrepreneur herself, lived this reality after her youngest daughter was diagnosed with a severe neurodevelopmental disorder. What started as a deeply personal struggle evolved into something much larger: a mission to harness artificial intelligence not just for information, but as a true partner in care. Today, that vision has become a platform designed to act as an AI advocate for thousands of families navigating the complex, often lonely world of rare diseases.
From Personal Pain to Powerful Platform: The Birth of Citizen Health
I’ve always believed that the most meaningful innovations often come from those who have felt the problem in their bones. This story is no exception. When faced with a diagnosis offering little guidance, no approved treatments, and virtually no roadmap, many parents turn to online groups hoping for wisdom from strangers. The information feels random at best, unreliable at worst. What if technology could change that equation entirely?
That’s exactly the question two experienced tech entrepreneurs asked themselves. One brought deep expertise in building consumer health platforms, the other carried the fire of a parent who refused to accept limited options for her child. Together, they launched a company in 2023 with a bold goal: create an AI-powered system that empowers rare disease patients and their families rather than leaving them to fend for themselves.
The result is a platform that collects and organizes medical records, genetic data, and real patient experiences — all with explicit consent. It builds communities around specific conditions while feeding anonymized insights back to researchers working on new therapies. Most impressively, it’s now rolling out agentic AI — technology that doesn’t just answer questions but takes meaningful actions on behalf of users.
In rare disease, a parent will spend on average 53 hours a week taking care above and beyond the ordinary parenting that anyone might have to do.
That statistic hits hard because it captures the invisible labor so many families endure. It’s not just the medical tasks — it’s the emotional weight, the coordination, the constant advocacy. Giving even a portion of those hours back could transform lives. And that’s precisely what this new AI advocate aims to do: schedule appointments, handle insurance appeals, flag important details in medical records, and connect people with others facing similar challenges.
Understanding the Unique Challenges of Rare Diseases
Rare diseases, by definition, affect small numbers of people. Yet collectively, they impact millions worldwide. The difficulty lies in the fragmentation. For common conditions, doctors have protocols, research papers abound, and treatment guidelines are well-established. For rare ones, even top specialists may have seen only a handful of cases. Public information is often nonexistent or outdated.
Families frequently describe a diagnostic odyssey that lasts years. Once diagnosed, the journey doesn’t end — it shifts into managing symptoms with limited tools while hoping for breakthroughs that feel perpetually out of reach. Many parents end up founding their own research organizations or even attempting to become amateur scientists. It’s inspiring, but it’s also unsustainable for most.
Here’s where the system breaks down further. Traditional healthcare AI trained on massive public datasets struggles with rarity. If almost no published research exists for a specific genetic mutation, large language models have nothing solid to draw from. The result? Generic advice or, worse, confident-sounding but irrelevant suggestions. Families still default to Facebook groups, crossing their fingers that the shared anecdote applies to their situation.
This platform takes a different approach. It works directly with patients and advocacy groups to build rich, consented datasets specific to each condition. Over time, with more than 8,000 patients already participating across hundreds of diseases, it creates a living knowledge base. Users can query it for practical answers tailored to real experiences rather than theoretical possibilities.
How the AI Advocate Actually Works in Daily Life
Imagine having a reliable assistant who knows every detail of your child’s medical history without you having to repeat it endlessly. One that reminds you when a test result needs follow-up or spots patterns across years of records that a busy doctor might miss. That’s the promise of agentic AI in this context — systems that act, not just inform.
The tool can pull records from multiple providers, organize them intelligently, and then use that context to help with practical tasks. Need to schedule a specialist visit? It can assist. Facing an insurance denial? It helps prepare appeals with relevant data points. Worried about a new symptom? It cross-references against similar patient journeys to suggest questions worth asking the care team.
Automated appointment coordination across multiple specialists
Insurance navigation and appeal preparation
Medical record analysis with personalized alerts
Matching with patients experiencing comparable symptoms or treatments
Connections to relevant clinical trials based on genetic and clinical profiles
Perhaps most powerfully, it taps into collective community wisdom without forcing families to hunt through scattered posts. When one parent discovers that adjusting a particular therapy improved mobility in their child, that insight — properly anonymized and validated — can reach others facing the same condition much faster than traditional channels allow.
In my view, this represents a meaningful shift from passive information consumption to active partnership. Technology stops being another thing to learn and starts functioning like a trusted member of the care team — one that never sleeps, never forgets, and always prioritizes the patient’s specific context.
The Dual Mission: Better Care Today, Faster Cures Tomorrow
What makes this initiative particularly compelling is its dual focus. On one side, it delivers immediate relief to families drowning in administrative and emotional labor. On the other, it accelerates research by making high-quality, patient-consented data available to scientists and pharmaceutical companies.
Patients using the platform can choose to share their de-identified information for research purposes. Remarkably, participation rates hover around 98 percent — a testament to how many families want their experiences to help others, even amid their own challenges. When commercial researchers access this data, the platform shares revenue back with contributing patients, creating a new model of partnership rather than extraction.
This approach has already shown tangible results. In one foundation’s work tied to a specific genetic syndrome, aggregated patient data helped refine clinical trial endpoints, shifting focus from one symptom set to another that better reflected real priorities for families. That seemingly small change contributed to skipping an entire phase of trials, potentially saving significant time and resources while still maintaining scientific rigor.
We’ve been able to reduce timelines to get these therapies to market where they’re actually built on what patients need by 30%-50%.
Reducing development timelines by nearly half isn’t just impressive — it’s life-changing for conditions where every year counts. Children grow, symptoms progress, and windows for intervention can close. By grounding research in real-world patient data from the start, therapies have a better chance of addressing what actually matters most to those living with the condition.
The Caregiver Experience: Beyond the Numbers
Let’s pause for a moment and consider the human side more deeply. Caring for a child with complex medical needs often means becoming an expert in fields you never studied. You learn to read lab results, negotiate with insurance companies, coordinate between specialists who don’t always communicate with each other, and maintain hope when progress feels agonizingly slow.
The emotional toll is enormous. Many caregivers report feeling isolated even when surrounded by support because few people truly understand the nuances of their daily reality. The constant vigilance — watching for subtle changes that could signal a medical shift — leaves little room for rest or normal family activities.
Here’s something I’ve observed in stories from this community: the most exhausted parents are often the ones who refuse to give up. They push for better answers, better treatments, better systems. Technology that lightens the load without diminishing their central role as advocate feels like a genuine gift rather than a replacement.
The AI doesn’t make decisions for families. Instead, it equips them with better information and frees up mental bandwidth for the things only a parent can do — providing love, comfort, and personalized care that no algorithm could replicate.
Building Trust Through Transparency and Consent
In healthcare, especially involving sensitive data from vulnerable populations, trust isn’t optional — it’s foundational. This platform seems designed with that principle in mind. Usage remains free for patients and families. Data sharing is always opt-in, with clear controls. When revenue comes from commercial use of aggregated insights, a portion returns directly to the individuals who contributed.
That revenue-sharing model feels refreshingly different from traditional approaches where patient data often benefits others without clear reciprocity. It acknowledges that people living with these conditions are active partners in advancing science, not merely subjects of study.
Privacy considerations receive serious attention too. The system handles complex medical histories while maintaining strict security standards. For families already navigating enough uncertainty, knowing their information is protected matters deeply.
Real-World Impact: Stories Behind the Statistics
While numbers like funding raised or patients enrolled tell part of the story, the individual experiences reveal the true potential. One mother described finally being able to sit fully present with her child during a doctor’s visit because the AI advocate had already compiled and summarized the relevant history. No more frantically trying to recall details from years of appointments.
Another aspect involves connecting families across distances. A parent in one region might discover management strategies that worked for similar genetic profiles, then share questions or successes that benefit someone else thousands of miles away. These peer connections, facilitated intelligently rather than left to chance, can reduce the sense of isolation that so often accompanies rare diagnoses.
On the research side, the ability to use natural history data from real patients as a control arm in trials represents a significant advancement. It respects the ethical concerns around placebo use in serious conditions while still generating robust evidence. For ultra-rare disorders where recruiting enough participants is extraordinarily difficult, this approach could unlock progress that seemed previously impossible.
The Broader Implications for Healthcare and AI
This initiative doesn’t exist in isolation. It reflects larger conversations about how artificial intelligence can serve medicine without losing the human element. General-purpose AI has limitations in specialized domains, but when trained thoughtfully on curated, consented data from the specific population it aims to help, the results become far more relevant and actionable.
There’s also a philosophical shift worth noting. Rather than patients being passive recipients of care, they’re positioned as central drivers — their experiences, preferences, and data helping shape both individual treatment plans and collective research priorities. That empowerment model could influence how we approach many chronic and complex conditions beyond just rarity.
Of course, challenges remain. Ensuring equitable access, maintaining data quality as the platform grows, and continuously refining the AI to handle the incredible variability within even “rare” categories will require ongoing attention. Yet the foundation being built — combining technological sophistication with deep empathy — offers genuine reason for optimism.
Looking Ahead: What This Means for Families
For newly diagnosed families, the landscape could look markedly different in the coming years. Instead of starting from scratch with limited resources, they might gain immediate access to a knowledgeable companion that helps them ask better questions, connect with the right experts, and contribute meaningfully to broader understanding of their condition.
The ultimate vision seems to be one where no family feels they must become experts in rare disease navigation simply to get basic care. Where the burden lightens enough that parents can focus more on being parents and less on being full-time medical logisticians. And where the collective knowledge of thousands accelerates discoveries that benefit everyone.
It’s worth remembering that behind every dataset point is a real person — a child learning to navigate the world with unique challenges, a parent fighting for every possible advantage, a family trying to build joy amid uncertainty. Technology that respects that humanity while amplifying it deserves close attention.
As we watch developments in this space unfold, one thing feels clear: the intersection of compassionate entrepreneurship and thoughtful AI application holds tremendous potential. Not as a magic solution that erases all difficulties, but as a powerful tool that returns agency to those who need it most.
The journey for rare disease families will always involve courage, resilience, and love in extraordinary measures. Yet with advocates — both human and artificial — standing alongside them, that path might become a little less lonely and a lot more hopeful. And in the world of rare conditions, hope grounded in real progress is perhaps the most valuable resource of all.
What strikes me most is how this story reminds us that innovation often blooms from necessity and personal connection. When technology meets lived experience, the results can transcend what either could achieve alone. For thousands of families worldwide, that convergence couldn’t come at a more important time.
